Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 19 Aug 2026. Factsheet Jun 2026. About · Disclosures
Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment
Baroda BNP Paribas Mutual Fund₹10.7072
As on 19 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +8.37% | — | — |
| 3 year | +6.15% | — | — |
| 5 year | +6.15% | — | — |
All Sectoral Pharma and Healthcare funds · Baroda BNP Paribas Mutual Fund
Returns
From NAVs through 19 Aug 2026
Calendar years
Fund facts
Fund details from the Jun 2026 factsheet
Where the money is invested
Split by asset type.
By asset type
What the fund holds
38 holdings · portfolio as on 30 May 2026
- 9.09%Sun Pharmaceuticals Industries LtdHealthcare
- 5.83%Lupin LtdHealthcare
- 5.76%Laurus Labs LtdHealthcare
- 5.43%Abbott India LtdHealthcare
- 5.27%Torrent Pharmaceuticals LtdHealthcare
- 5.18%Ipca Laboratories LtdHealthcare
- 4.66%Apollo Hospitals Enterprise LtdHealthcare
- 4.38%J.B. Chemicals & Pharmaceuticals LtdHealthcare
- 4.27%Fortis Healthcare LtdHealthcare
- 4.12%Astrazeneca Pharma India LtdHealthcare
Concentration
Risk and quality measures
How steady the returns have been.
Return quality
Risk
Who manages this fund
1 fund manager
- SCSanjay Chawla16.4 years in the industryRuns 15 schemes
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Growth-InsuredregularCompare
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund IDCW PayoutregularCompare
Bandhan Healthcare FundregularCompare
Bandhan BSE Healthcare Index Fund - Regular Plan - GrowthregularCompare
ICICI Prudential Healthcare ETFregularCompare
Axis Healthcare ETF Regular GrowthregularCompare
Motilal Oswal S&P BSE Healthcare ETFregularCompare
Nippon India Nifty Pharma ETF - Growth PlanregularCompare
SIP illustration
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- directIDCWBaroda BNP Paribas Health and Wellness Fund - Direct Plan - IDCW PayoutNAV ₹9.91
- regularIDCWBaroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW PayoutNAV ₹9.85
- directGrowthBaroda BNP Paribas Health and Wellness Fund - Direct Plan - GrowthNAV ₹9.91
- regularGrowthBaroda BNP Paribas Health and Wellness Fund - Regular Plan - GrowthNAV ₹9.85
FAQ
What is Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment NAV today?
- The latest NAV of Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment is ₹10.7072 as on 19 Aug 2026.
How has Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment performed vs its category?
- 1-year return +8.37%. Past performance does not guarantee future returns.
What are the returns of Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment?
- Trailing returns from published NAVs: 1 year +8.37%, 3 year +6.15% a year, 5 year +6.15% a year, since our first NAV +6.15% a year. Past performance does not guarantee future returns.
How would a SIP in Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +6.15%. It is not a forecast.
What is the expense ratio and fund size of Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment?
- For Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment, the expense ratio is 2.08% and fund size (AUM) is ₹544.17 Cr.
What is the ISIN of Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment?
- The ISIN for Baroda BNP Paribas Health and Wellness Fund - Regular Plan - IDCW Reinvestment is INF251K01UZ4.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.
